Attachment 6 - Sample Client Letter for Past Performance.docx
DOCX document 17 KB Posted
- Solicitation number
- 75F40124R00002
About this file
This document is a Sample Client Letter for Past Performance related to Solicitation Number 75F40124R00002 for the Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST 3): Data Sources for Surveillance of Biologics. The letter requests the client complete a Past Performance Evaluation Questionnaire and submit it via email to the FDA Contract Specialist, Nick Sartain, by the closing date and time of the solicitation. The FDA placed emphasis on past performance as a key source selection factor and requires that clients of entities responding to the solicitation be identified and their participation in the evaluation process be requested.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Amendment 3 Attachment 1 HHSAR Clauses and Provisions.docx | DOCX document | |
| Amendment 3.pdf | ||
| Amendment 3 Attachment 2 BEST 3 Task Order 1 SOW.docx | DOCX document | |
| Amendment 3 Attachment 3 Solicitation 75F40124R00002 BEST 3.pdf | ||
| amendment 2 attachment 1 Solicitation 75F40124R00002 BEST 3.pdf | ||
| amendment 2.pdf | ||
| amendment 1.pdf | ||
| Attachment 3 - Wage Determination.pdf | ||
| Attachment 5 - Past Performance Evaluation Questionnaire.docx | DOCX document | |
| Attachment 1 BEST3 IDIQ PWS.docx | DOCX document | |
| Attachment 2 BEST 3 Task Order 1 SOW.docx | DOCX document | |
| Attachment 4 FDA Form 3398.pdf | ||
| 75F40124R00002.pdf |
Show all 13
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
ATTACHMENT 5 – SAMPLE CLIENT LETTER
Solicitation Number: 75F40124R00002
Dear Client, We are currently responding to Solicitation Number 75F40124R00002 for the Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST 3): Data Sources for Surveillance of Biologics.
The FDA placed emphasis on past performance as a key source selection factor and requiring that clients of entities responding to their solicitations be identified and their participation in the evaluation process be requested.
Therefore, enclosed is a Past Performance Evaluation Questionnaire for your completion. We are requesting that you complete the questionnaire and send it via email to nick.sartain@fda.hhs.gov no later than the closing date/time of the phase II solicitation: 1:00 PM date ________________________:
If you have questions regarding the attached questionnaire, or require assistance, please contact Nick Sartain, FDA Contract Specialist at 870-543-7370 or nick.sartain@fda.hhs.gov.
We thank you for your prompt response in this matter.
Sincerely, {Offering Entity}
File details come from the government source that posted it. Updated .